Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement
A 68-year-old man presented with chest distress recurring for the past 10 years. An echocardiogram demonstrated bicuspid aortic valve malformation with severe aortic stenosis and ventricular septal thickness of 22 mm. The patient underwent successful transcatheter aortic valve replacement (TAVR). Si...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2020-01-01
|
| Series: | Cardiology Plus |
| Subjects: | |
| Online Access: | http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2020;volume=5;issue=2;spage=97;epage=100;aulast=Wang |
| _version_ | 1811249414397755392 |
|---|---|
| author | Jian-An Wang Xin-Ping Lin Ju-Bo Jiang Xian-Bao Liu Jun Jiang Zhao-Xia Pu Li-Han Wang Hua-Jun Li Fei Lv |
| author_facet | Jian-An Wang Xin-Ping Lin Ju-Bo Jiang Xian-Bao Liu Jun Jiang Zhao-Xia Pu Li-Han Wang Hua-Jun Li Fei Lv |
| author_sort | Jian-An Wang |
| collection | DOAJ |
| description | A 68-year-old man presented with chest distress recurring for the past 10 years. An echocardiogram demonstrated bicuspid aortic valve malformation with severe aortic stenosis and ventricular septal thickness of 22 mm. The patient underwent successful transcatheter aortic valve replacement (TAVR). Six months later, he complained of worsening dyspnea and chest distress (New York Heart Association Class III) on exertion. Besides a functional normal AV prosthesis, the echocardiography indicated the left ventricular outflow tract obstruction peak gradient of 122 mmHg at rest. Alcohol septal ablation was performed as the patient was unable to tolerate morrow procedure. His symptoms were relieved immediately after ablation, and no major cardiovascular events were observed during the 20-month follow-up. In conclusion, among patients with concomitant hypertrophic obstructive cardiomyopathy and severe aortic valvular stenosis, consideration for TAVR and alcohol septal ablation should only be made for patients who are at high surgical risk or cannot tolerate thoracotomy. |
| first_indexed | 2024-04-12T15:46:06Z |
| format | Article |
| id | doaj.art-104c3b2b851846058ca84df4a74288ea |
| institution | Directory Open Access Journal |
| issn | 2470-7511 2470-752X |
| language | English |
| last_indexed | 2024-04-12T15:46:06Z |
| publishDate | 2020-01-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Cardiology Plus |
| spelling | doaj.art-104c3b2b851846058ca84df4a74288ea2022-12-22T03:26:38ZengWolters Kluwer Health/LWWCardiology Plus2470-75112470-752X2020-01-01529710010.4103/cp.cp_12_20Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacementJian-An WangXin-Ping LinJu-Bo JiangXian-Bao LiuJun JiangZhao-Xia PuLi-Han WangHua-Jun LiFei LvA 68-year-old man presented with chest distress recurring for the past 10 years. An echocardiogram demonstrated bicuspid aortic valve malformation with severe aortic stenosis and ventricular septal thickness of 22 mm. The patient underwent successful transcatheter aortic valve replacement (TAVR). Six months later, he complained of worsening dyspnea and chest distress (New York Heart Association Class III) on exertion. Besides a functional normal AV prosthesis, the echocardiography indicated the left ventricular outflow tract obstruction peak gradient of 122 mmHg at rest. Alcohol septal ablation was performed as the patient was unable to tolerate morrow procedure. His symptoms were relieved immediately after ablation, and no major cardiovascular events were observed during the 20-month follow-up. In conclusion, among patients with concomitant hypertrophic obstructive cardiomyopathy and severe aortic valvular stenosis, consideration for TAVR and alcohol septal ablation should only be made for patients who are at high surgical risk or cannot tolerate thoracotomy.http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2020;volume=5;issue=2;spage=97;epage=100;aulast=Wangablation techniquesalcoholsventricular outflow obstructionheart valve prosthesis implantationtranscatheter aortic valve replacement |
| spellingShingle | Jian-An Wang Xin-Ping Lin Ju-Bo Jiang Xian-Bao Liu Jun Jiang Zhao-Xia Pu Li-Han Wang Hua-Jun Li Fei Lv Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement Cardiology Plus ablation techniques alcohols ventricular outflow obstruction heart valve prosthesis implantation transcatheter aortic valve replacement |
| title | Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement |
| title_full | Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement |
| title_fullStr | Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement |
| title_full_unstemmed | Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement |
| title_short | Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement |
| title_sort | alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy in a patient with prior transcatheter aortic valve replacement |
| topic | ablation techniques alcohols ventricular outflow obstruction heart valve prosthesis implantation transcatheter aortic valve replacement |
| url | http://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2020;volume=5;issue=2;spage=97;epage=100;aulast=Wang |
| work_keys_str_mv | AT jiananwang alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT xinpinglin alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT jubojiang alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT xianbaoliu alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT junjiang alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT zhaoxiapu alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT lihanwang alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT huajunli alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement AT feilv alcoholseptalablationforthetreatmentofhypertrophicobstructivecardiomyopathyinapatientwithpriortranscatheteraorticvalvereplacement |